R. Giacomelli et al., SERUM LEVELS OF SOLUBLE CD30 ARE INCREASED IN ULCERATIVE-COLITIS (UC)BUT NOT IN CROHNS-DISEASE (CD), Clinical and experimental immunology, 111(3), 1998, pp. 532-535
Imbalance in Th1 and Th2 subsets and their derived cytokines seems to
be involved in the immune abnormalities underlying UC and CD. CD30 is
a member of the tumour necrosis factor/nerve growth receptor superfami
ly expressed on T cells producing Th2 cytokines and released as a solu
ble form. In this study high levels of soluble CD30 were found in sera
of UC patients independently of disease activity. Furthermore, increa
sed titres of soluble CD30 molecule were shown, in the same patients,
by mitogen-stimulated cultures of peripheral blood mononuclear cells.
Our data seem to indicate that an activation of Th2 immune response is
involved in the pathogenesis of UC, but not of CD. Furthermore, this
finding indicates that serum soluble CD30 measurement may be helpful f
or differentiating these two forms of inflammatory bowel disease.